StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)

Close on Nov 17, 2026Market cap $4.48BP/E –Yield –

Ionis Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Ionis Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$496.43M. For fiscal 2025 it was -$268.58M. The highest annual figure on record is $602.91M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$268.58M–
FY2024Dec 31, 2024-$500.95M–
FY2023Dec 31, 2023-$307.51M–
FY2022Dec 31, 2022-$274.37M-990.8%
FY2021Dec 31, 2021$30.80M-14.2%
FY2020Dec 31, 2020$35.89M-89.6%
FY2019Dec 31, 2019$345.63M-42.7%
FY2018Dec 31, 2018$602.91M+246.2%
FY2017Dec 31, 2017$174.15M–
FY2016Dec 31, 2016-$112.11M-630.7%
FY2015Dec 31, 2015$21.13M+236.1%
FY2014Dec 31, 2014$6.29M-90.1%
FY2013Dec 31, 2013$63.49M+3284.5%
FY2012Dec 31, 2012$1.88M–
FY2011Dec 31, 2011-$111.93M–
FY2010Dec 31, 2010-$63.59M–
FY2009Dec 31, 2009-$108.44M-151.1%
FY2008Dec 31, 2008$212.03M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$565.53M+273.7%
Q1 FY2026Mar 31, 2026-$792.82M–
Q4 FY2025Dec 31, 2025-$137.71M–
Q3 FY2025Sep 30, 2025-$131.44M–
Q2 FY2025Jun 30, 2025$151.34M–
Q1 FY2025Mar 31, 2025-$150.78M–
Q4 FY2024Dec 31, 2024-$116.14M-453.4%
Q3 FY2024Sep 30, 2024-$114.99M–
Q2 FY2024Jun 30, 2024-$119.88M–
Q1 FY2024Mar 31, 2024-$149.94M–
Q4 FY2023Dec 31, 2023$32.87M–
Q3 FY2023Sep 30, 2023-$109.02M–
Q2 FY2023Jun 30, 2023-$97.36M–
Q1 FY2023Mar 31, 2023-$133.99M–
Q4 FY2022Dec 31, 2022-$200.20M-198.3%
Q3 FY2022Sep 30, 2022-$24.43M–
Q2 FY2022Jun 30, 2022-$18.10M–
Q1 FY2022Mar 31, 2022-$31.65M–
Q4 FY2021Dec 31, 2021$203.69M+107.9%
Q3 FY2021Sep 30, 2021-$55.57M–
Q2 FY2021Jun 30, 2021-$62.65M–
Q1 FY2021Mar 31, 2021-$54.66M–
Q4 FY2020Dec 31, 2020$97.98M-64.7%
Q3 FY2020Sep 30, 2020-$10.28M–
Q2 FY2020Jun 30, 2020-$44.22M–
Q1 FY2020Mar 31, 2020-$7.59M-107.0%
Q4 FY2019Dec 31, 2019$277.84M+140.5%
Q3 FY2019Sep 30, 2019-$12.81M–
Q2 FY2019Jun 30, 2019-$27.11M-105.4%
Q1 FY2019Mar 31, 2019$107.71M+718.1%
Q4 FY2018Dec 31, 2018$115.51M+466.2%
Q3 FY2018Sep 30, 2018-$26.00M-190.5%
Q2 FY2018Jun 30, 2018$500.24M+21069.6%
Q1 FY2018Mar 31, 2018$13.17M-89.3%
Q4 FY2017Dec 31, 2017$20.40M–
Q3 FY2017Sep 30, 2017$28.72M+18.3%
Q2 FY2017Jun 30, 2017$2.36M–
Q1 FY2017Mar 31, 2017$122.67M–
Q4 FY2016Dec 31, 2016-$26.84M–
Q3 FY2016Sep 30, 2016$24.29M–

More Ionis Pharmaceuticals figures

See a number that looks wrong?